Kong Garheng
SEC insider (Form 3/4/5 filer). CIK 0001435183. Director at Xeris Biopharma Holdings, Inc. (XERS) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in CHICAGO, IL.
Companies Kong Garheng has filed insider reports for
- Xeris Biopharma Holdings, Inc. (XERS): Director
- LABCORP HOLDINGS INC. (LH): Director
Kong Garheng
CIK: 0001435183
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 4, 2026XERS
Xeris Biopharma Holdings, Inc.
AwardDirect24.2K shares- - Feb 11, 2026LH
LABCORP HOLDINGS INC.
ExerciseDirect897 shares- - Feb 10, 2026LH
LABCORP HOLDINGS INC.
AwardDirectRestricted Stock Unit
773 shares- - Jun 4, 2025XERS
Xeris Biopharma Holdings, Inc.
AwardDirect50K shares- - Feb 11, 2025LH
LABCORP HOLDINGS INC.
AwardDirectRestricted Stock Unit
897 shares- - Feb 6, 2025LH
LABCORP HOLDINGS INC.
ExerciseDirect944 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  XERS Xeris Biopharma Holdings, Inc. | Award | 24,193 | - | $0 | Direct |
| Feb 11, 2026 |  LH LABCORP HOLDINGS INC. | Exercise | 897 | - | $0 | Direct |
| Feb 10, 2026 | LH LABCORP HOLDINGS INC. | Award Restricted Stock Unit | 773 | - | - | Direct |
| Jun 4, 2025 | XERS Xeris Biopharma Holdings, Inc. | Award | 50,000 | - | - | Direct |
| Feb 11, 2025 | LH LABCORP HOLDINGS INC. | Award Restricted Stock Unit | 897 | - | - | Direct |
| Feb 6, 2025 | LH LABCORP HOLDINGS INC. | Exercise | 944 | - | - | Direct |
1-6 of 6 transactions